On April 24, the 6th Asian Network Meeting (ANM) was held in a combination of online and offline sessions. Heads of national medical products regulatory authorities of China, India, Indonesia, Japan, South Korea, Malaysia, the Philippines, Singapore, Thailand and Vietnam shared their latest regulatory status and engaged in the in-depth exchanges around topics such as innovative drug R&D in Asia from a regulatory perspective, digitization, and enhancing drug accessibility for patients. Huang Guo, Deputy Commissioner of the NMPA, attended the meeting by video and delivered a speech.

During the meeting, the representative from the Chinese side highlighted that in recent years, the National Medical Products Administration has actively promoted the reform of the drug review and approval system, strengthened the quality and safety supervision of the whole life cycle, and made every effort to promote the innovative and high-quality development within the pharmaceutical industry. It is hoped that through the exchanges, we can jointly promote the enhancement of drug regulatory capacity and standards in the Asian region.